Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | GABRP | O00591 | 1/20 | 0.53 |
| ▸ | GABRD | O14764 | 1/20 | 0.53 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.53 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.53 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.53 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.53 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.53 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.53 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.53 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.53 |
| ▸ | GABRE | P78334 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29501103 | 1.00 | ALDH1A1 (0.58) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL10989791 | 0.92 | ALDH1A1 (0.54) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL31544289 | 0.90 | HCRTR1 (0.50) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL5030843 | 0.90 | ALDH1A1 (0.50) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL19612305 | 0.89 | ALDH1A1 (0.47) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL9681191 | 0.85 | ALDH1A1 (0.48) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL23373094 | 0.85 | ALDH1A1 (0.48) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL11244864 | 0.85 | GABRP (0.60) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL12520420 | 0.85 | MAPT (0.60) | ALDH1A1KDM4EKMT2AMAPTRAB9A | |
| SCHEMBL21479797 | 0.84 | PMM2 (0.58) | ALDH1A1KDM4EKMT2AMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 850 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116323829-A | Ink composition for inkjet, cured product thereof, light conversion layer, color filter, and light-emitting element | DIC株式会社 | 2023-06-23 | — | — | CN | claimed |
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| WO-2022107599-A1 | INKJET INK COMPOSITION, CURED PRODUCT THEREOF, LIGHT CONVERSION LAYER, COLOR FILTER, AND LIGHT EMITTING ELEMENT | DIC株式会社 | 2022-05-27 | — | — | WO | claimed |
| CN-107652222-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2021-09-10 | — | — | CN | claimed |
| US-10919909-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2021-02-16 | — | — | US | claimed |
| EP-2852374-B1 | PROCESS FOR DYEING KERATIN FIBRES COMPRISING A DYE/PIGMENT, A PHOTOACTIVE COMPOUND AND A LIGHT SOURCE | OREAL (FR) | 2019-08-21 | — | — | EP | claimed |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2019-07-11 | — | — | US | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| EP-2852374-A1 | PROCESS FOR DYEING KERATIN FIBRES COMPRISING A DYE/PIGMENT, A PHOTOACTIVE COMPOUND AND A LIGHT SOURCE | L'Oréal (FR) | 2015-04-01 | — | — | EP | claimed |
| WO-2013174871-A1 | PROCESS FOR DYEING KERATIN FIBRES COMPRISING A DYE/PIGMENT, A PHOTOACTIVE COMPOUND AND A LIGHT SOURCE | L'OREAL (FR) | 2013-11-28 | — | — | WO | claimed |
| CN-101802022-B | Photoinitiators for energy curing | LAMBERTI SPA | 2013-03-27 | — | — | CN | claimed |
| EP-2190887-B1 | PHOTOINITIATORS FOR ENERGY CURING | LAMBERTI SPA (IT) | 2011-05-04 | — | — | EP | claimed |
| CN-101802022-A | Photoinitiators for energy curing | LAMBERTI SPA | 2010-08-11 | — | — | CN | claimed |
| US-20100196826-A1 | Photoinitiators for Energy Curing | LAMBERTI SPA (IT) | 2010-08-05 | — | — | US | claimed |
| EP-2190887-A1 | PHOTOINITIATORS FOR ENERGY CURING | Lamberti Spa (IT) | 2010-06-02 | — | — | EP | claimed |
| US-20100093883-A1 | Hydroxamic Esters as Photoinitiators | LAMBERTI SPA (IT) | 2010-04-15 | — | — | US | claimed |
| EP-2121323-A1 | HYDROXAMIC ESTERS AS PHOTOINITIATORS | Lamberti Spa (IT) | 2009-11-25 | — | — | EP | claimed |
| WO-2009037130-A1 | PHOTOINITIATORS FOR ENERGY CURING | LAMBERTI SPA (IT) | 2009-03-26 | — | — | WO | claimed |
| WO-2008104436-A1 | HYDROXAMIC ESTERS AS PHOTOINITIATORS | LAMBERTI SPA (IT) | 2008-09-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919909-B2 | Photoinitiated reactions | KMO, DECR1, PPOX | ALDH1A1 262/4885KDM4E 2292/4885KMT2A 1865/4885 |
| US-20100196826-A1 | Photoinitiators for Energy Curing | PPOX, ECPAS, PTGES | ALDH1A1 434/4885KDM4E 1954/4885KMT2A 1137/4885 |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | DOHH, PAH, DBH | ALDH1A1 179/4885KDM4E 1292/4885KMT2A 2037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.